To address the translational potential of TMEM44-AS1/Myc, we identified the Myc inhibitor, Myci975, as a selective inhibitor of glioma cell growth, which further validates our finding that Myc is a downstream effector of TMEM44-AS1. This evidence concerns the gene MYC and central nervous system cancer.